— Know what they know.
Not Investment Advice
Also trades as: ACR.AX (ASX) · $vol 0M

ARUXF OTC

Acrux Limited
1W: +0.0% 1M: +0.0% 3M: -80.5% YTD: -79.7% 1Y: -93.4% 3Y: -89.0% 5Y: -97.5%
$0.00
+0.00 (+0.00%)
 
OTC · Healthcare · Biotechnology · Tech Score Sell · Power 44 · $1.3M mcap · 308M float · 0.0086% daily turnover · Short 71% of daily vol

Income Trends

Revenue
$5M +289.7% ▲
5Y CAGR: +28.2%
Gross Profit
$4M +253.0% ▲
Operating Income
-$2M +76.2% ▲
Net Income
-$603K +89.9% ▲
EPS (Diluted)
$-0.00 +91.7% ▲
EBITDA
-$2M +67.1% ▲

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2022FY2023FY2024FY2025FY2026
Revenue$2M$8M$5M$1M$5M
YoY Growth+28.6%+390.3%-39.6%-76.6%+289.7%
Cost of Revenue$6M$558K$4M$0$437K
Gross Profit-$5M$8M$1M$1M$4M
Gross Margin-270.6%93.4%22.3%100.0%90.6%
R&D Expenses$6M$4M$2M$2M$1M
SG&A Expenses$6M$6M$6M$6M$5M
Operating Expenses$13M$10M$10M$10M$6M
Operating Income-$18M-$6M-$9M-$9M-$2M
Operating Margin-1027.6%-70.1%-168.4%-753.9%-46.1%
Interest Expense$0$0$0$303K$282K
Income Before Tax-$10M-$212K-$6M-$6M-$2M
Tax Expense$252K$552K$232K$8K-$2M
Net Income-$10M-$764K-$6M-$6M-$603K
Net Margin-572.1%-9.1%-113.9%-499.6%-13.0%
EPS (Diluted)$-0.03$-0.00$-0.02$-0.02$-0.00
EBITDA-$12M-$3M-$8M-$5M-$2M
Shares Outstanding284M286M289M352M423M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms